BioNTech SE
NASDAQ: BNTX
$88.01
+$1.20 (+1.4%)
Closing price April 22, 2024
24/7 Wall St. looks at some big analyst calls that we have seen so far on Tuesday, including BioNTech, Denali Therapeutics, Exelixis, Foot Locker and Hostess Brands.
Published:
After a quiet Friday afternoon, March quarter earnings hit the ground running again before markets open Monday. More than 1,500 earnings reports are expected next week.
Published:
Here are five stocks that reported earnings in the past week and all posted better-than-expected numbers and investors rewarded them with higher share prices.
Published:
Two interesting earnings reports are due early next week. One is recent entry in the electric vehicle market and the other is a co-developer of a COVID-19 vaccine.
Published:
BioNTech was in the spotlight on Tuesday after it received a sizable price target hike from one key analyst.
Published:
COVID-19 stocks were on the move on Wednesday after a few huge updates in regards to vaccine approval.
Published:
Tuesday's top analyst upgrades and downgrades included BioNTech, Charles Schwab, FedEx, First Solar, Micron Technologies, Nio, Occidental Petroleum, Salesforce.com, Square and Zoom Video...
Published:
Here is an update on the stocks of each major player in the COVID-19 arena, including brief trading histories and consensus price targets.
Published:
Shares of COVID-19 vaccine duo Pfizer and BioNTech made handy gains on Wednesday after they announced their late-stage coronavirus study had concluded.
Published:
Moderna reported a 95.4% effectiveness rate for its COVID-19 vaccine. This is the second vaccine to hit more than 90% efficacy in the past week.
Published:
Pfizer and BioNTech stocks both exploded on Monday after these companies provided an update on their coronavirus vaccine.
Published:
The novel coronavirus has wiped out trillions of dollars in global output with more than 1 million deaths worldwide in 2020. With cases rising rapidly in the United States and in Europe, more...
Published:
While other companies seem to be struggling with their coronavirus vaccines, Pfizer and BioNTech are just picking up speed. Pfizer’s CEO has provided an update on their COVID-19 vaccine.
Published:
Wednesday's top analyst upgrades and downgrades included Apple, BioNTech, Intel, Microsoft, Nio, Oracle, Peloton Interactive, Salesforce.com and Williams-Sonoma.
Published:
Many health care products become much more popular because of endorsements and advertising efforts. It is a longstanding practice that has come under fire by both political parties in the United...
Published: